Treatment‐free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide
- 9 December 1994
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 37 (12) , 1784-1794
- https://doi.org/10.1002/art.1780371212
Abstract
Objective. To investigate the effect of an intensified treatment protocol synchronizing plasmapheresis with subsequent pulse cyclophosphamide for severe systemic lupus erythematosus (SLE). Methods. A protocol of plasmapheresis (3 x 60 ml/kg) and subsequent high‐dose pulse cyclophosphamide (36 mg/kg) followed by 6 months of peroral immunosuppression was used to treat 14 patients with severe SLE. Results. Rapid improvement was achieved in all patients. Immunosuppressants, including corticosteroids, were withdrawn at month 6 in 12 patients. Eight patients continued without treatment for a mean observation period of 5.6 years (46–91 months). Conclusion. The results demonstrate that treatment‐free clinical remission can be achieved in some patients with severe SLE.Keywords
This publication has 36 references indexed in Scilit:
- Timing of Pregnancy in Relation to the Onset of Rheumatoid ArthritisArthritis & Rheumatism, 1992
- Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: Design of the LPSG trialJournal of Clinical Apheresis, 1991
- Antibody response to pneumococcal polysaccharide vaccine in Myasthenia gravis: Effect of therapeutic plasmapheresisJournal of Clinical Apheresis, 1990
- Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- Predictive value of clinical, laboratory, pathologic, and treatment variables in steroid/lmmunosuppressive resistant lupus nephritisJournal of Clinical Apheresis, 1988
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Plasmapheresis in systemic lupus erythematosus. a cautionary noteArthritis & Rheumatism, 1981
- Different Suppressive Effects of Combined Cyclophosphamide-Antigen Treatment Compared with Exclusive Cyclophosphamide Treatment on Primary and Secondary Humoral Immune ReactivityInternational Archives of Allergy and Immunology, 1978
- Immunological Tolerance induced by Cyclophosphamide assayed by Plaque Spleen Cell MethodNature, 1967